Clinical Trials on Racism in China
Total 1 results
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingPrimary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1China
Sponsors and Collaborators
- Montera Health Texas LLC
- Stanford's Innovative Medicines Accelerator
- Ancon Technologies Ltd
- Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
- Health Factors Inc
- Robert Pendleton
- Michael Scharl
- AVAX Technologies
- Genesis Foundation
- Daqiao Community Health Service Center of Yangpu District
- National Institute of Drug Abuse
- Ondine Biomedical Inc.
- University Mental Health Research Institute, Athens, Greece
- Manresana de Micobacteriologia, SL
- National Institute of Diabetes and Endocrinology, Egypt
- Prostate Cure Foundation
- Azumio Inc.
- Spokane Regional Health District
- Julie Lefevere
- Rotem Petranker
- View Full List
Medical Conditions
- Immunochromatographic
- Connective Active Program
- Isolation of Enterococci From Samples
- Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)
- Convalescent Plasma for COVID 19
- Skin Burn Multiple
- Pain Due to Childhood Vaccination
- Desmoid
- Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
- Simulation Training, Laparoscopy
- Glanzmann's Thrombasthenia
- Unwanted Abdomen Fat
- Peripheral Artery Calcification
- Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
- Age of Probands 18 - 55 Years
- Acute Myocardial Infarction With ST Segment Elevation
- Ischemic Stroke, Cryptogenic
- Vital Signs
- Thymoglobulin Dose
- Universal Adhesive
- View Full List
Drug Interventions
- Treament C
- Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
- Megestrol Acetate 160 MG
- Ciclesonide
- Uprifosbuvir
- DKN-01
- Nab-paclitaxel
- Golcadomide
- PD-0332991
- Mild sedation and analgesia
- Administration of etoricoxib
- Formulation N3
- Colchicine group (experimental arm)
- Bevacizumab
- Single dose of vepdegestrant as tablet formulation (Treatment A)
- G-CSF
- JNJ 10229570-AAA 3.6% cream
- Human menopausal gonadotropin
- GM-CSF
- Glycopyrrolate
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Belarus
- Contract Research Organizations in Burundi
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Finland
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Malta
- Contract Research Organizations in Mongolia
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Russia
- CRO list by country